Fig. 1: Gene expression level of ROR2 is higher in adjacent normal prostate tissues as compared with primary prostate tumors and is lowest in metastatic prostate tumors.

Gene expression level of ROR2 in adjacent normal prostate tissues, primary prostate tumors, and metastatic prostate tumors was analyzed in (a) TCGA–PRAD database (52 normal prostate tissues, 498 primary prostate tumors), (b) Chandran Prostate dataset (10 primary prostate tumors, 21 metastatic prostate tumors), (c) Varambally Prostate dataset (7 primary prostate tumors, 6 metastatic prostate tumors), (d) Ramaswamy Multi-Cancer dataset-1 (10 primary prostate tumors, 4 metastatic prostate tumors), (e) La Tulippe Prostate dataset (3 adjacent normal prostate tissues, 23 primary prostate tumors, and 9 metastatic prostate tumors), (f) Taylor Prostate dataset (29 adjacent normal prostate tissues, 131 primary prostate tumors, and 19 metastatic prostate tumors), (g) Yu Prostate dataset (23 adjacent normal prostate tissues, 64 primary prostate tumors, and 25 metastatic prostate tumors), (h) Grasso (28 adjacent normal prostate tissues, 59 primary prostate tumors, and 35 metastatic prostate tumors) dataset. Statistical significance was shown by the p value between the two groups being compared.